Trial to Evaluate the Improvement of Chronic Low-grade AEs in Patients With Ph+ CML With Optimal Response to Imatinib When Switched to Nilotinib
Clinical trial NCT02115386 · TERMINATED
Trial details
- NCT number
- NCT02115386
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-17
- Primary completion
- 2016-10-31
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.